A brain cancer survivor, Romain Clément is the CEO of ArcaScience, a healthtech company founded in 2018 that leverages artificial intelligence to enhance drug prediction, safety, and performance. Together with his team, he transforms biomedical knowledge into predictive insights to accelerate R&D, strengthen treatment safety, and better target patients. He also teaches at Paris I Panthéon-Sorbonne, where he lectures on philosophy contextualized by the industrialization of AI, data pipelines, and the impact of evidence-driven decision-making.